Page last updated: 2024-09-03

omega-n-methylarginine and 8-bromoguanosino-3',5'-cyclic monophosphorothioate

omega-n-methylarginine has been researched along with 8-bromoguanosino-3',5'-cyclic monophosphorothioate in 1 studies

Compound Research Comparison

Studies
(omega-n-methylarginine)
Trials
(omega-n-methylarginine)
Recent Studies (post-2010)
(omega-n-methylarginine)
Studies
(8-bromoguanosino-3',5'-cyclic monophosphorothioate)
Trials
(8-bromoguanosino-3',5'-cyclic monophosphorothioate)
Recent Studies (post-2010) (8-bromoguanosino-3',5'-cyclic monophosphorothioate)
4,41134433690027

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Laurentiis, A; Duvilanski, B; Lasaga, M; Pisera, D; Rettori, V; Seilicovich, A1

Other Studies

1 other study(ies) available for omega-n-methylarginine and 8-bromoguanosino-3',5'-cyclic monophosphorothioate

ArticleYear
Neurokinin A inhibits oxytocin and GABA release from the posterior pituitary by stimulating nitric oxide synthase.
    Brain research bulletin, 2000, Volume: 53, Issue:3

    Topics: Animals; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; gamma-Aminobutyric Acid; Hypothalamus; In Vitro Techniques; Male; Neurokinin A; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxytocin; Pituitary Gland, Posterior; Potassium; Rats; Rats, Wistar; Thionucleotides

2000